Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cells
by
Farahzadi, Raheleh
, Fathi, Ezzatollah
in
Acute myeloid leukemia
/ Cytokines
/ ERK signaling pathways
/ Gene expression
/ Leukemia
/ Mesenchymal stem cells
/ Stem cells
/ Telomerase
/ Telomerase activity
/ Telomere length
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cells
by
Farahzadi, Raheleh
, Fathi, Ezzatollah
in
Acute myeloid leukemia
/ Cytokines
/ ERK signaling pathways
/ Gene expression
/ Leukemia
/ Mesenchymal stem cells
/ Stem cells
/ Telomerase
/ Telomerase activity
/ Telomere length
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cells
by
Farahzadi, Raheleh
, Fathi, Ezzatollah
in
Acute myeloid leukemia
/ Cytokines
/ ERK signaling pathways
/ Gene expression
/ Leukemia
/ Mesenchymal stem cells
/ Stem cells
/ Telomerase
/ Telomerase activity
/ Telomere length
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cells
Journal Article
Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cells
2022
Request Book From Autostore
and Choose the Collection Method
Overview
A predominant challenge in the discovery approach to curative leukemia is investigating the effect of mesenchymal stem cells (MSCs) on leukemic cells. We aimed to investigate the role of MSCs in targeting telomerase enzyme and consequently telomere length of leukemic cells. For this purpose, the KG1 cell as leukemia cell line was co-cultured with MSCs in the trans-well system. After seven days of co-culture, KG1 cells were collected, and telomerase activity, telomere length, and hTERT gene expression were analyzed by PCR-ELISA TRAP assay and real-time PCR, respectively. Also, the potentially involved ERK pathway was analyzed at gene and protein levels by real time PCR and flow cytometry, respectively. It was found that MSCs caused a significant decrease in telomerase activity, telomere length, and hTERT gene expression. The following results showed that MSCs resulted in a significant decrease in the ERK expression levels. It can be concluded that the co-culture of MSCs with KG1 cells be involved in the telomerase targeting via ERK signaling pathways. This study concluded that the co-culture of MSCs with AML leukemic cells could secrete a significant amount of cytokines that cause to inhibit the proliferation of AML cell lines via ERK signaling pathway. The recognition of cytokines as well as growth factors involved in the anti-proliferative effect of MSCs requires further investigation. This effect as a therapeutic strategy could be considered in the basic experimental studies.
Publisher
Tehran University of Medical Sciences
This website uses cookies to ensure you get the best experience on our website.